Abdominal pain, a common complaint in clinical practice, presents a diagnostic challenge due to its broad differential diagnoses. This article aims to provide a comprehensive approach to evaluating such cases, enhancing diagnostic accuracy and patient management.
Initial assessment should focus on identifying 'red flags' suggestive of serious pathology. A detailed history, encompassing the nature, location, onset, duration, and associated symptoms of the pain, is crucial. Special attention should be given to factors that exacerbate or alleviate the pain, as well as any relevant past medical or surgical history.
Physical examination should be systematic, starting with inspection and palpation, followed by auscultation and percussion. The presence of scars, distension, or visible peristalsis provides valuable clues. Tenderness, guarding, or rigidity may indicate underlying pathology, while specific signs can suggest certain diagnoses.
Basic laboratory tests, including complete blood count, liver and renal function tests, and inflammatory markers, can guide further investigations. Imaging studies, such as ultrasound or computed tomography, are often necessary to confirm the diagnosis. More specialized tests, like endoscopy or colonoscopy, may be required based on clinical suspicion.
Management should be tailored to the underlying cause. Analgesia, while often necessary, should not compromise the clinical assessment. Patients with non-specific abdominal pain may require reassessment or further investigations if symptoms persist. A clear follow-up plan is essential to ensure appropriate care.
Abdominal pain evaluation requires a methodical approach, incorporating a thorough history, physical examination, and judicious use of investigations. Recognizing 'red flags', understanding the limitations of physical findings and investigations, and tailoring management to the individual patient are key to successful outcomes in this challenging area of clinical practice.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation